The European Commission acknowledges the significance and the effective work done by the European Digital Media Observatory (EDMO) consortium and extends its work with a second term to intensify its actions in tackling disinformation in Europe.
The European Commission acknowledges the significance and the effective work done by the European Digital Media Observatory (EDMO) consortium and extends its work with a second term to intensify its actions in tackling disinformation in Europe.
Athens Technology Center S.A. is pleased to announce our participation in the Horizon Europe project, LibrarIN. The three-year project, launched on November 1st 2022, receives funding in the Horizon Europe call Research and innovation on cultural heritage and CCIs.
Are you studying or working in the healthcare industry or in computer science? Do you want to know more on how AI and ML techniques can be used to predict the quality of life and the toxicity profile of cancer patients?
EU-funded project IDIH – International Digital Health Cooperation for Preventive, Integrated, Independent and Inclusive Living, in which ATC is a partner, has recently ended.
On 13 and 14 June the European Digital Media Observatory (EDMO) will hold its 2022 Annual Conference in Radisson Collection Hotel, Grand Place Brussels.
FENCE / Building resilience for safeguarding political debates in EU SE frontiers aims to address the problem of disinformation in line with EDMO’s main objectives.
MediaMotorEurope (MME), a project co-funded by the European Commission’s Horizon 2020 programme, aimed to nurture high-potential European deeptech innovators solving today’s most prominent media industry challenges (including misinformation and fake news, protection of personal data) and support them in building scalable media solutions. After 3 open calls, 3 support cycles and 61 selected and supported startups, MME ended in April 2022.
The vision of the ImmuneAI project is to reveal the patients with the greatest survival benefit by retrieving baseline clinical and biological characteristics of long-term survivors with immunotherapy.